Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Vaccine. 2010 Aug 9;28(35):5664-8. doi: 10.1016/j.vaccine.2010.06.061.

    Evaluation of seasonal influenza vaccination effectiveness based on antibody efficacy among the institutionalized elderly in Japan.

    Source

    Department of Preventive Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan. harameg@cc.saga-u.ac.jp

    Abstract

    Influenza vaccination efficacy was evaluated in 114 institutionalized elderly people in 2002/03. Strain A/H3N2 was isolated; 44 and 8 subjects had sudden-onset fever (> or = 37.8 degrees C) and kit-diagnosed influenza, respectively. Odds ratios adjusted for age, sex, comorbidity, and vaccine strain (OR(adj)) were determined using multiple logistic regression. Seroprotected patients (haemagglutination-inhibition antibody titre > or = 1:40) had lower incidence of fever (OR(adj), 0.35; 95% confidence interval [CI], 0.09-1.28) and kit-diagnosed influenza (OR(adj), 0.35; 95% CI, 0.03-4.64) than patients without seroprotection (antibody efficacy, approximately 65%). Seroprotective levels of vaccination-induced antibodies probably prevent influenza among the institutionalized elderly, although statistical significance could not be confirmed owing to the sample size.

    Copyright 2010 Elsevier Ltd. All rights reserved.

    PMID:
    20600482
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk